February 29, 2016 Bio/Pharma/CRO M&A, Partnerships

JHL Biotech Announces Mechanical Completion of its Wuhan Biopharmaceutical Manufacturing Facility

WUHAN, China and AMERSHAM, England, Feb. 25, 2016 /PRNewswire/ — JHL Biotech (TPEx: 6540) and GE Healthcare’s Life Sciences business (NYSE: GE) are proud to announce mechanical completion of JHL Biotech’s JHL-1 biopharmaceutical manufacturing facility in the Biolake area of Wuhan, China. The campus was built to be compliant with the highest international standards, and after site validation is completed in June... Read more

February 23, 2016 Microscopy

Researchers first to prove ZIKA Virus associated with Microcephaly Used JEOL Transmission Electron Microscopes (TEM) for imaging brain sections

FOR IMMEDIATE RELEASE CONTACT:Patricia Corkum, Marketing Manager978-536-2273 • pcorkum@jeol.com • www.jeolusa.com Scientists from the Institute of Microbiology and Immunology and the Institute of Pathology in Ljubljana, Slovenia are the first in the world to publish and prove that the ZIKA virus is associated with Microcephaly (New England Journal of Medicine, February 10, 2016). ZIKV was found... Read more

February 19, 2016 Uncategorized

Greiner Bio-One Expands Site in Kremsmünster

Greiner Bio-One is further expanding its site in Kremsmünster through an investment totaling EUR 9.3 million. “The new development will provide maximum flexibility in terms of how we use the space, enabling us to further optimize our work processes,” says Rainer Perneker, Division Director of Greiner Bio-One International. Additional stories will be added to the... Read more

February 18, 2016 Informatics & Software Product Launch

New Agreements Underscore QIAGEN’s Leadership in Bioinformatics

HILDEN, Germany and AARHUS, Denmark, February 2, 2016 /PRNewswire/ — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced new partnerships to enhance the profile and expand the use of its market leading bioinformatics solutions for microbiome, metagenomics and other applications. QIAGEN Bioinformatics signed an agreement with genomics big data company CosmosID, Inc. to... Read more

February 3, 2016 Microscopy Product Launch

New JEOL “F2” Versatile S/TEM Offers Advanced Analytical Features

FOR IMMEDIATE RELEASE CONTACT:Patricia Corkum, Marketing Manager978-536-2273 • pcorkum@jeol.com • www.jeolusa.com (February 3, 2016 — Peabody, MA) — JEOL’s most recent addition to its suite of Transmission Electron Microscopes is the versatile JEM-F200, or “F2,” the only advanced analytical, high throughput 200kV S/TEM in its class to offer a Cold Field Emission Gun and dual Silicon... Read more

January 21, 2016 Clinical Research/Diagn. Lab Top-10

New Access TSH (3rd IS) Assay Released with CE Mark for Use on the Beckman Coulter Access Family of Immunoassay Systems

  NYON, SWITZERLAND – (January 21, 2016) – Beckman Coulter Diagnostics is pleased to announce obtaining CE Mark and the release of its new Access TSH (3rd IS) assay for use with the company’s Access Family of Immunoassay Systems. This new assay is the next generation of the Access HYPERsensitive hTSH and Access Fast hTSH... Read more

January 15, 2016 Microscopy

JEOL USA Announces Grand Prize winners for 2015 SEM & TEM Image Contest

(January 14, 2016 — Peabody, MA) — JEOL USA selected two Grand Prize winners from a large collection of customer images submitted to the 2015 Image Contest throughout the calendar year. While one image was selected to win each month, the Grand Prize images exhibited the very best composition and resolution, and demonstrated excellent technical... Read more

January 15, 2016 Microscopy PR/Corporate

JEOL USA Announces Grand Prize winners for 2015 SEM & TEM Image Contest

FOR IMMEDIATE RELEASE CONTACT:Patricia Corkum, Marketing Manager978-536-2273 • pcorkum@jeol.com • www.jeolusa.com (January 14, 2016 — Peabody, MA) — JEOL USA selected two Grand Prize winners from a large collection of customer images submitted to the 2015 Image Contest throughout the calendar year. While one image was selected to win each month, the Grand Prize images exhibited... Read more

January 13, 2016 Clinical Research/Diagn.

GE Healthcare, FedDev Ontario commit CAD $40M for new CCRM-led centre to solve cell therapy manufacturing challenges

Chalfont St. Giles, UK and Toronto, Canada – 13 January 2016 – GE Healthcare, the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), and the Centre for Commercialization of Regenerative Medicine (CCRM) are building a centre for advanced therapeutic cell technologies in Toronto with an investment of CAD $40M from GE and FedDev Ontario.... Read more